EMA Adopts a New Pharmaceutical Form of Selumetinib By Ogkologos - December 16, 2025 315 0 Facebook Twitter Google+ Pinterest WhatsApp It is associated with an extension to the existing indication Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer July 8, 2020 Teen With Terminal Cancer Gives Make-A-Wish Gift To Other Kids In... December 4, 2019 Study Advances Fertility Preservation Approach for Male Cancer Survivors April 24, 2019 Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life September 30, 2021 Load more HOT NEWS Belzutifan Shows a Significant Benefit Over Everolimus in Patients with Advanced... Brentuximab Approved for Initial Treatment of Advanced Hodgkin Lymphoma ¿Cómo están cambiando los requisitos de elegibilidad para los ensayos clínicos... Girl Whose Insides Were Sucked From Her Body While Sitting On...
